MPharma : a candid founder interview
A clear-eyed look at whether $a payments API can $win enterprise clients.
MPharma : a candid founder interview
- How Senegal's market shapes the outcome.
- The real cost behind the growth round.
- The practical move an operator can make this quarter.
A clear-eyed look at whether $a payments API can $win enterprise clients.
- How Senegal's market shapes the outcome.
- The real cost behind the growth round.
- The practical move an operator can make this quarter.
For anyone building in podcasts, the useful question is where this changes your costs, distribution or competition — and how soon you act on it.
AI-generated summary. It can miss nuance — read the full story above for the complete picture.
Another week, another move from mPharma — but this one changes how operators should think about board management.
The team's bet is simple: win enterprise clients without burning the runway that Visa just extended.
Why it matters
In this economy, unit economics are the strategy.
For most founders, the lesson isn't the raise — it's the discipline around board management that made it possible.
Competitors won't sit still. Expect incumbents to respond within the quarter.
What to watch next
- How the a payments API performs outside the launch market.
- Which rivals move first, and how incumbents counter.
- How Senegal's regulators respond over the next two quarters.
For now, mPharma has bought itself time — and a story worth studying.
